Clinical Trials Browser

Colitis, Feeding Behavior, Colorectal Neoplasms

NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Phase 1 Recruiting

800 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

NCT04305145 2026-01-29

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Phase 2 Active not recruiting

42 enrolled

Dermatologic

Colitis, Melanoma, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04407247 2025-12-23

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Phase 1/2 Active not recruiting

47 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Melanoma, Urogenital Neoplasms

NCT06206707 2025-11-17

Immunobiome

Phase NA Recruiting

20 enrolled

DermatologicGenitourinary

Colitis, Diarrhea, Kidney Neoplasms, Melanoma

NCT02814864 2021-08-03

PRISME

Phase 2 Unknown

12 enrolled

Colitis, Diarrhea, Hemorrhage

NCT03601611 2020-04-21

COLAR

Phase NA Completed

20 enrolled

Arthritis, Colitis

NCT03548948 2019-09-27

Obesity, Iron Regulation and Colorectal Cancer Risk

Phase NA Completed

17 enrolled

Other

Colitis, Obesity

NCT00518349 2018-05-29

Colonoscope Passive Bending Function

Phase NA Completed

120 enrolled 6 charts

Gastrointestinal

Adenoma, Carcinoma, Colitis, Colonic Diseases, Functional

NCT01369329 2016-12-07

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Phase 3 Completed

769 enrolled 13 charts

Colitis, Crohn Disease, Inflammatory Bowel Diseases

NCT00533078 2015-07-23

LUNCH1

Phase 2 Completed

14 enrolled

Other

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Phase 2 Completed

190 enrolled

Lymphoid

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer

NCT00237276 2007-09-24

Experience and Enhancement: Improving Colonoscopic Polyp Detection

Phase NA Unknown

30 enrolled

Gastrointestinal

Adenoma, Colitis, Polyps, Colorectal Neoplasms

Clinical Trials

Walnuts and Colon Health

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Immunobiome

PRISME

COLAR

Obesity, Iron Regulation and Colorectal Cancer Risk

Colonoscope Passive Bending Function

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

LUNCH1

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Experience and Enhancement: Improving Colonoscopic Polyp Detection